Drug Name
(Proprietary name/Generic name)

Indications Addressed
Click on indication to see all drugs for that indication

Company
Click a company to see all drugs for that company

Development Status

Notes

ANA 971
none / none

Hepatitis C

Anadys Pharmaceuticals
San Diego, CA

Phase I

Ceplene
none / histamine dihydrochloride

Hepatitis C

Maxim Pharmaceuticals
San Diego, CA

Phase II

Civacir
Civacir / hepatitis C immune globulin intraveous (human)

Hepatitis C

Nabi
Boca Raton, FL

Phase I/II/Phase I

EHC18
none / none

Hepatitis C

Enzo Biochem
Farmingdale, NY

Phase I completed

HCV-086
none / none

Hepatitis C

ViroPharma
Exton, PA

Phase I

HepeX-C (XLT002)
none / none

Hepatitis C

XTL Biopharmaceuticals
New Ipswich, NY

Phase II

IDN-6556 (Orphan Drug)
none / none

Hepatitis B
Hepatitis C
Liver Desease, Chronic

Idun Pharmaceuticals
San Diego, CA

Phase II

isatoribine (ANA 245)
none / none

Hepatitis C

Anadys Pharmaceuticals
San Diego, CA

Phase I/II

ISIS 14803
ISIS 14803 / none

Hepatitis C

ISIS Pharmaceuticals
Carlsbad, CA

Phase II

MBI-3253 (celgosivir)
none / none

Hepatitis C

Micrologix Biotech
Vancouver, British Columbia

Phase I/II

merimempodib
none / none

Hepatitis C

Vertex Pharmaceuticals
Cambridge, MA

Phase II

Multiferon
none / human leukocyte alpha interferon

Hepatitis C

Viragen
Plantation, FL

Phase III/completed

NM283
none / none

Hepatitis C

Idenix Pharmceuticals
Cambridge, MA

Phase II

omega interferon (Biomed 510)
none / none

Hepatitis C

BioMedicines
Alameda, CA

Phase II

PEG-alfacon-1
none / none

Hepatitis C

InterMune
Brisbane, CA

phase I

PEG-Infergen
none / none

Hepatitis C

InterMune Pharmaceuticals
Brisbane, CA

Phase I

R1479 polymerase inhibitor
none / none

Hepatitis C

Roche
Nutley, NJ

Phase I

Viramidine
none / none

Hepatitis C

Valeant Pharmaceuticals
Costa Mesa, CA

Phase II